| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-19-2016, 04:29 AM
|
#1 | |||
|
||||
|
Senior Member
|
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
|
 Reply With Quote
|
|
12-19-2016, 08:28 AM
|
#2 | ||
|
|||
|
Senior Member
|
This is good news. In my opinion publicly funded institutions should not patent their research. The strategy of trying to get a portfolio of patents:
- distorts the priorities of what should be researched; - makes collaboration harder; - leads to excessive prices; - diverts research money to the lawyers. I have nothing against private sector companies applying for patents, providing that they act responsibly. John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
|
|
Reply With Quote
|
| "Thanks for this!" says: | olsen (12-19-2016) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Jefferson gets $20M gift to expand neuroscience institute | ALS News & Research | |||
| NEWS: Couple give $2-million gift for the center’s planned Neuroscience Institute | Parkinson's Disease | |||
McGill's Neuroscience Institute and open science
Linear Mode
